Correlation Between Molecular Partners and Ventyx Biosciences
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Ventyx Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Ventyx Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Ventyx Biosciences, you can compare the effects of market volatilities on Molecular Partners and Ventyx Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Ventyx Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Ventyx Biosciences.
Diversification Opportunities for Molecular Partners and Ventyx Biosciences
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Molecular and Ventyx is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Ventyx Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ventyx Biosciences and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Ventyx Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ventyx Biosciences has no effect on the direction of Molecular Partners i.e., Molecular Partners and Ventyx Biosciences go up and down completely randomly.
Pair Corralation between Molecular Partners and Ventyx Biosciences
Given the investment horizon of 90 days Molecular Partners AG is expected to under-perform the Ventyx Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Molecular Partners AG is 1.06 times less risky than Ventyx Biosciences. The stock trades about -0.01 of its potential returns per unit of risk. The Ventyx Biosciences is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 221.00 in Ventyx Biosciences on August 31, 2024 and sell it today you would earn a total of 44.00 from holding Ventyx Biosciences or generate 19.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. Ventyx Biosciences
Performance |
| Timeline |
| Molecular Partners |
| Ventyx Biosciences |
Molecular Partners and Ventyx Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and Ventyx Biosciences
The main advantage of trading using opposite Molecular Partners and Ventyx Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Ventyx Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ventyx Biosciences will offset losses from the drop in Ventyx Biosciences' long position.| Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
| Ventyx Biosciences vs. Arcellx | Ventyx Biosciences vs. Immunocore Holdings | Ventyx Biosciences vs. Vaxcyte | Ventyx Biosciences vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets |